{"entity":{"type":"insider","cik":"0001327442","url":"/insider/0001327442","json_url":"/insider/0001327442.json","name":"Fickenscher James E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":23,"first":"2005-11-14","last":"2023-09-14","span_basis":"filed_date"},"name_variants":[{"name":"Fickenscher James E","source":"filing","n_filings":23,"first_seen":"2005-11-14","last_seen":"2023-09-14"}],"transactions":[{"id":7840238,"accession":"0001062993-23-018020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-018020","line_url":"/filing/0001062993-23-018020#line-2","is_derivative":false,"issuer_cik":"0001327442","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001327442","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8998.0,"shares_display":"8,998","price_per_share":1.3257,"price_display":"1.33","price_state":"stated","total_value":11928.6486,"total_display":"11,928.65","total_whole":"11,929","shares_owned_after":378087.0,"shares_owned_after_display":"378,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-14","scope":"insider"},{"id":8218009,"accession":"0001062993-23-001386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-001386","line_url":"/filing/0001062993-23-001386#line-1","is_derivative":false,"issuer_cik":"0001327442","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001327442","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17769.0,"shares_display":"17,769","price_per_share":0.5978,"price_display":"0.60","price_state":"stated","total_value":10622.3082,"total_display":"10,622.31","total_whole":"10,622","shares_owned_after":154736.0,"shares_owned_after_display":"154,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":6123785,"accession":"0001062993-22-016556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-016556","line_url":"/filing/0001062993-22-016556#line-2","is_derivative":false,"issuer_cik":"0001327442","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001327442","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6013.0,"shares_display":"6,013","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":6614.3,"total_display":"6,614.30","total_whole":"6,614","shares_owned_after":172505.0,"shares_owned_after_display":"172,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-20","scope":"insider"},{"id":6853377,"accession":"0001192482-18-000383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000383","line_url":"/filing/0001192482-18-000383#line-1","is_derivative":false,"issuer_cik":"0001327442","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001327442","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8518.0,"shares_display":"8,518","price_per_share":5.9688,"price_display":"5.97","price_state":"stated","total_value":50842.2384,"total_display":"50,842.24","total_whole":"50,842","shares_owned_after":20718.0,"shares_owned_after_display":"20,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-06","filed_date":"2018-08-07","scope":"insider"},{"id":4112286,"accession":"0001123292-17-000929","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000929","line_url":"/filing/0001123292-17-000929#line-1","is_derivative":false,"issuer_cik":"0001327442","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001327442","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5200.0,"shares_display":"5,200","price_per_share":19.82,"price_display":"19.82","price_state":"stated","total_value":103064.0,"total_display":"103,064.00","total_whole":"103,064","shares_owned_after":12200.0,"shares_owned_after_display":"12,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-12","filed_date":"2017-05-16","scope":"insider"},{"id":2426604,"accession":"0001123292-16-003042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-16-003042","line_url":"/filing/0001123292-16-003042#line-2","is_derivative":false,"issuer_cik":"0001327442","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001327442","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":14.03,"price_display":"14.03","price_state":"stated","total_value":56120.0,"total_display":"56,120.00","total_whole":"56,120","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-07","filed_date":"2016-12-08","scope":"insider"},{"id":2426600,"accession":"0001123292-16-003042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-003042","line_url":"/filing/0001123292-16-003042#line-1","is_derivative":false,"issuer_cik":"0001327442","issuer_name":"Zynerba Pharmaceuticals, Inc.","issuer_ticker":"ZYNE","issuer_name_source":null,"issuer_url":"/issuer/0001327442","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":14.15,"price_display":"14.15","price_state":"stated","total_value":42450.0,"total_display":"42,450.00","total_whole":"42,450","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-06","filed_date":"2016-12-08","scope":"insider"},{"id":2923212,"accession":"0001209191-16-109633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-109633","line_url":"/filing/0001209191-16-109633#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Senior Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":135000.0,"shares_display":"135,000","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":97200.0,"total_display":"97,200.00","total_whole":"97,200","shares_owned_after":270216.0,"shares_owned_after_display":"270,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-18","filed_date":"2016-03-21","scope":"insider"},{"id":6258081,"accession":"0001181431-14-038873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-038873","line_url":"/filing/0001181431-14-038873#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Senior Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":2.495,"price_display":"2.50","price_state":"stated","total_value":99800.0,"total_display":"99,800.00","total_whole":"99,800","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-15","scope":"insider"},{"id":5271770,"accession":"0001209191-13-056561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-056561","line_url":"/filing/0001209191-13-056561#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71067.0,"shares_display":"71,067","price_per_share":20.3674,"price_display":"20.37","price_state":"stated","total_value":1447450.0158,"total_display":"1,447,450.02","total_whole":"1,447,450","shares_owned_after":45132.0,"shares_owned_after_display":"45,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-11","filed_date":"2013-12-12","scope":"insider"},{"id":8978970,"accession":"0001209191-11-054779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-054779","line_url":"/filing/0001209191-11-054779#line-1","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1610.0,"shares_display":"1,610","price_per_share":15.5429,"price_display":"15.54","price_state":"stated","total_value":25024.069,"total_display":"25,024.07","total_whole":"25,024","shares_owned_after":26839.0,"shares_owned_after_display":"26,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-03","filed_date":"2011-11-07","scope":"insider"},{"id":5655080,"accession":"0001209191-09-044650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-044650","line_url":"/filing/0001209191-09-044650#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":30.7027,"price_display":"30.70","price_state":"stated","total_value":122810.8,"total_display":"122,810.80","total_whole":"122,811","shares_owned_after":17751.0,"shares_owned_after_display":"17,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-14","filed_date":"2009-09-16","scope":"insider"},{"id":5607087,"accession":"0001209191-09-043816","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-043816","line_url":"/filing/0001209191-09-043816#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":30.0018,"price_display":"30.00","price_state":"stated","total_value":120007.2,"total_display":"120,007.20","total_whole":"120,007","shares_owned_after":17751.0,"shares_owned_after_display":"17,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-10","scope":"insider"},{"id":5590724,"accession":"0001209191-09-036995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-036995","line_url":"/filing/0001209191-09-036995#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":30.0062,"price_display":"30.01","price_state":"stated","total_value":120024.8,"total_display":"120,024.80","total_whole":"120,025","shares_owned_after":17751.0,"shares_owned_after_display":"17,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-15","filed_date":"2009-07-17","scope":"insider"},{"id":5693663,"accession":"0001209191-09-032862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-032862","line_url":"/filing/0001209191-09-032862#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":27.2097,"price_display":"27.21","price_state":"stated","total_value":108838.8,"total_display":"108,838.80","total_whole":"108,839","shares_owned_after":17751.0,"shares_owned_after_display":"17,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-15","filed_date":"2009-06-17","scope":"insider"},{"id":5654579,"accession":"0001209191-09-029128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-029128","line_url":"/filing/0001209191-09-029128#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":25.023,"price_display":"25.02","price_state":"stated","total_value":100092.0,"total_display":"100,092.00","total_whole":"100,092","shares_owned_after":17751.0,"shares_owned_after_display":"17,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-22","filed_date":"2009-05-27","scope":"insider"},{"id":5624327,"accession":"0001209191-09-022167","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-022167","line_url":"/filing/0001209191-09-022167#line-4","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":20759.0,"shares_owned_after_display":"20,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-17","filed_date":"2009-04-20","scope":"insider"},{"id":5624325,"accession":"0001209191-09-022167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-022167","line_url":"/filing/0001209191-09-022167#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":25.0094,"price_display":"25.01","price_state":"stated","total_value":87532.9,"total_display":"87,532.90","total_whole":"87,533","shares_owned_after":20759.0,"shares_owned_after_display":"20,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-16","filed_date":"2009-04-20","scope":"insider"},{"id":6012884,"accession":"0001209191-09-016991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-016991","line_url":"/filing/0001209191-09-016991#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4933.0,"shares_display":"4,933","price_per_share":29.7907,"price_display":"29.79","price_state":"stated","total_value":146957.5231,"total_display":"146,957.52","total_whole":"146,958","shares_owned_after":21281.0,"shares_owned_after_display":"21,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-16","filed_date":"2009-03-17","scope":"insider"},{"id":5719091,"accession":"0001209191-09-010525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-010525","line_url":"/filing/0001209191-09-010525#line-1","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3450.0,"shares_display":"3,450","price_per_share":31.547,"price_display":"31.55","price_state":"stated","total_value":108837.15,"total_display":"108,837.15","total_whole":"108,837","shares_owned_after":21281.0,"shares_owned_after_display":"21,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-17","filed_date":"2009-02-19","scope":"insider"},{"id":5645701,"accession":"0001209191-09-003616","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-003616","line_url":"/filing/0001209191-09-003616#line-1","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3942.0,"shares_display":"3,942","price_per_share":29.0373,"price_display":"29.04","price_state":"stated","total_value":114465.0366,"total_display":"114,465.04","total_whole":"114,465","shares_owned_after":22280.0,"shares_owned_after_display":"22,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-14","filed_date":"2009-01-16","scope":"insider"},{"id":2403496,"accession":"0001209191-08-067057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-067057","line_url":"/filing/0001209191-08-067057#line-1","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11675.0,"shares_display":"11,675","price_per_share":26.3062,"price_display":"26.31","price_state":"stated","total_value":307124.885,"total_display":"307,124.88","total_whole":"307,125","shares_owned_after":26222.0,"shares_owned_after_display":"26,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-19","filed_date":"2008-12-22","scope":"insider"},{"id":7409655,"accession":"0001209191-07-029262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-029262","line_url":"/filing/0001209191-07-029262#line-1","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1510.0,"shares_display":"1,510","price_per_share":13.375,"price_display":"13.38","price_state":"stated","total_value":20196.25,"total_display":"20,196.25","total_whole":"20,196","shares_owned_after":37491.0,"shares_owned_after_display":"37,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-08","filed_date":"2007-05-10","scope":"insider"},{"id":3993159,"accession":"0001209191-06-017527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-017527","line_url":"/filing/0001209191-06-017527#line-1","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":6430.0,"total_display":"6,430.00","total_whole":"6,430","shares_owned_after":32447.0,"shares_owned_after_display":"32,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-10","filed_date":"2006-03-14","scope":"insider"},{"id":1366755,"accession":"0001209191-05-056929","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-05-056929","line_url":"/filing/0001209191-05-056929","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001327442","owner_name":"Fickenscher James E","owner_display_name":"Fickenscher James E","owner_url":"/insider/0001327442","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.2434,"price_display":"4.24","price_state":"stated","total_value":21217.0,"total_display":"21,217.00","total_whole":"21,217","shares_owned_after":1700.0,"shares_owned_after_display":"1,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-11","filed_date":"2005-11-14","scope":"insider","n_lines":16}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":25,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001621443","name":"Zynerba Pharmaceuticals, Inc.","url":"/issuer/0001621443","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2016-12-08","last_seen":"2023-09-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001016169","name":"ANTARES PHARMA, INC.","url":"/issuer/0001016169","role":"Officer (Senior Vice President & CFO)","n_filings":2,"first_seen":"2014-12-15","last_seen":"2016-03-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Officer (Chief Financial Officer)","n_filings":15,"first_seen":"2005-11-14","last_seen":"2013-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001327442","retrieved_at":"2026-08-24T22:56:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}